RxDoctor Payments Data

Robert Harris

Physician Assistant · Madera, CANPI 1841278553

Payments from drug & device makers

$776in general payments, 2019–2025

Across 42 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$81
  • GSK$59
  • Merck$55
  • Novo Nordisk$47
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
  • Cranial Technologies, Inc$38
  • plus $452 from 16 others

What the payments were for

  • Food & beverage$776100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$776 in reported general payments places this provider in the 65th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
TradjentaLinagliptin96$55,097
TrulicityDulaglutide42$39,994
JardianceEmpagliflozin38$25,590
JanuviaSitagliptin Phosphate37$25,112
XareltoRivaroxaban31$18,122
MounjaroTirzepatide16$17,407
EntrestoSacubitril/Valsartan26$16,903
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog62$16,738
OzempicSemaglutide17$15,300
EliquisApixaban21$15,252
BrilintaTicagrelor16$6,748
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,403
LinzessLinaclotide12$6,384
FarxigaDapagliflozin Propanediol13$5,908
Fiasp FlextouchInsulin Aspart (Niacinamide)11$4,641

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTradjenta, Jardiance$36$80,688134 claims
Lilly USA, LLCTrulicity, Mounjaro$81$57,40158 claims
MerckJanuvia$55$25,11237 claims
AstraZenecaBrilinta, Farxiga, Pulmicort Flexhaler$38$16,67847 claims
Novo NordiskOzempic$47$15,30017 claims
PfizerEliquis$38$15,25221 claims
GSKAnoro Ellipta$59$6,40313 claims
Sanofi-aventis U.S. LLCLantus$12$1,51013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Madera

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →